Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.
about
Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokineticsBotanicals and Their Bioactive Phytochemicals for Women's HealthEvaluation of various static and dynamic modeling methods to predict clinical CYP3A induction using in vitro CYP3A4 mRNA induction data.Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Therapeutic Risk and Benefits of Concomitantly Using Herbal Medicines and Conventional Medicines: From the Perspectives of Evidence Based on Randomized Controlled Trials and Clinical Risk Management.Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction.Two flavonolignans from milk thistle (Silybum marianum) inhibit CYP2C9-mediated warfarin metabolism at clinically achievable concentrationsPharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.Interactions between herbs and conventional drugs: overview of the clinical data.The effects of milk thistle (Silybum marianum) on human cytochrome P450 activity.Pregnane X receptor-mediated induction of Cyp3a by black cohosh.Black cohosh and breast cancer: a systematic review.Silybin and the liver: from basic research to clinical practice.Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patientsCytochrome P450 enzyme mediated herbal drug interactions (Part 1)Cytochrome P450 enzyme mediated herbal drug interactions (Part 2)Mass spectrometric dereplication of nitrogen-containing constituents of black cohosh (Cimicifuga racemosa L.).Ritonavir is the best alternative to ketoconazole as an index inhibitor of cytochrome P450-3A in drug-drug interaction studies.Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.In vitro metabolic interactions between black cohosh (Cimicifuga racemosa) and tamoxifen via inhibition of cytochromes P450 2D6 and 3A4.Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.Prediction of Drug-Drug Interactions Arising from CYP3A induction Using a Physiologically Based Dynamic ModelDrug interactions in the management of HIV infection: an update.Drugs as CYP3A probes, inducers, and inhibitors.Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John's Wort - and beyond!Fukinolic acid derivatives and triterpene glycosides from black cohosh inhibit CYP isozymes, but are not cytotoxic to Hep-G2 cells in vitro.Nitrogen-Containing Constituents of Black Cohosh: Chemistry, Structure Elucidation, and Biological Activities.Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions.Herb-drug interactions: challenges and opportunities for improved predictions.Clinically based evidence of drug-herb interactions: a systematic review.An Evidence-Based Systematic Review of Black cohosh (Cimicifuga racemosa, Actaea racemosa) by the Natural Standard Research Collaboration.Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based PharmacokinetDrug interactions in HIV treatment: complementary & alternative medicines and over-the-counter products.A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions.Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.Effects of herbal supplements on the bioactivation of chemotherapeutic agents.Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.PBPK Models for CYP3A4 and P-gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin
P2860
Q24656624-C127CD8B-57D6-44A7-8B64-968EBFA30521Q28065998-096E28EC-67C4-4403-9FBD-6B6263AECE7DQ30664468-8DF7829F-5354-46B8-BAAF-D05A3A4CF744Q33509452-D451AD9E-19B4-4A40-BC99-ADE6556ED852Q33604138-A3D48763-6501-4EA4-957B-5457B64E5AC2Q33702513-ECDA0571-3F4F-4108-B3E8-DEAFFBD1E0A9Q33714834-36FFBD58-FA16-4D97-A229-30D52E8E659CQ34108761-9D64789A-25CF-4376-9230-0855724515EFQ34124444-5B490387-25A7-4409-B460-184076A5B764Q34185982-D6464CAF-56C5-4B4C-85D7-D8B2A169358AQ34482267-6AEC4D66-A89B-46D6-94E9-4FAC7F41C684Q34601209-6B277B95-D980-4119-8F63-04962E110DFEQ34629765-A076ABAC-2FCC-4F00-AB40-A052C5BB5487Q34634353-29681FA3-2B84-4AE3-9E95-A67103C0CD12Q35092002-6F4E8F22-AC94-4835-B261-A1223D45C42CQ35725540-C5041A25-7864-4BA5-A513-75ABE2835F87Q35729029-25301340-DCF0-4888-BDEE-667D145FF5C6Q35926001-A725922F-647D-4B7A-9B05-88EFE6723664Q36072448-45348039-E7B9-4A22-840A-EE67D8389C1CQ36502919-F0EF75B0-E2C0-4F80-A2B5-D1167AF77963Q36589050-8680CBD3-7D6D-4DB1-B2F2-550F4EDF7E30Q36926307-8BDAD149-74CD-49A9-BE94-6A1662D48EBAQ36947718-2313B8EE-0CBD-4B7F-A291-036A61822B92Q37000733-01252208-659E-412D-9423-DFB6E10B7565Q37023996-CCEF7D65-14FC-4013-A742-0EDCFE52A1B2Q37118021-B787A3D3-4847-4870-BA88-2611A0C0EC92Q37144642-B5C68E68-A1AF-4B1E-9562-C20CA7AB97F6Q37375330-D5428B07-6A81-4555-A684-946030049019Q37440022-2F0B09D7-2537-4606-87D1-E2DB31A82DFBQ37603890-E051B861-0E20-4089-8E9E-7DF575973FDAQ37658866-C7D384CD-0365-420C-8CF0-CA30BD673B38Q38242928-216F0990-8DC8-4E17-8CFD-76BBA283F5C2Q38372360-943ACFCC-4964-4CE3-B957-002296769C96Q38974893-41BF49CF-C695-48CB-BC11-15996C4DA118Q41072555-D6D2303D-9709-4F4E-B4A1-24FBF8F5C092Q42074732-0A41C262-3CCD-4D8F-A012-ABB8D990D891Q43762616-3EFE9A26-690F-4905-96E7-A77029A82BF8Q48598672-A6B7B4E8-1E28-4CDF-B39B-878DEFBA42B0Q58758044-07F087BD-413B-46A9-9CD3-6B487EBEF77A
P2860
Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@ast
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@en
type
label
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@ast
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@en
prefLabel
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@ast
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@en
P2093
P2860
P356
P1476
Assessing the clinical signifi ...... o rifampin and clarithromycin.
@en
P2093
Bill Gurley
D Keith Williams
Danielle J Carrier
John Thaden
Martha A Hubbard
Philip Breen
Shreekar Cheboyina
W Brooks Gentry
Yudong Tong
P2860
P304
P356
10.1177/0091270005284854
P577
2006-02-01T00:00:00Z